333 related articles for article (PubMed ID: 16508878)
1. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia.
Combes A; Luyt CE; Trouillet JL
Semin Respir Crit Care Med; 2006 Feb; 27(1):23-8. PubMed ID: 16508878
[TBL] [Abstract][Full Text] [Related]
2. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
3. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
[TBL] [Abstract][Full Text] [Related]
4. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
Chastre J; Luyt CE; Combes A; Trouillet JL
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
[TBL] [Abstract][Full Text] [Related]
5. [A retrospective cohort study of the influence of time of hospital-acquired pneumonia onset on pathogen constitution].
Hu BJ; Wei L; Zhang XZ; Tang YC; Ni YX; Li YM; Guo JQ; Hu YJ; Zhang KX; Yang L
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):112-6. PubMed ID: 15854394
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
7. Ventilator-associated pneumonia complicating the acute respiratory distress syndrome.
Iregui MG; Kollef MH
Semin Respir Crit Care Med; 2001 Jun; 22(3):317-26. PubMed ID: 16088683
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
Paladino JA; Sunderlin JL; Forrest A; Schentag JJ
J Antimicrob Chemother; 2003 Sep; 52(3):457-63. PubMed ID: 12888598
[TBL] [Abstract][Full Text] [Related]
9. Outcome of late-onset hospital-acquired pneumonia related to causative organism.
McClure JR; Cooke RP; Lal P; Pickles D; Majjid S; Grant CA; Jones TM; Dempsey GA
J Hosp Infect; 2009 Apr; 71(4):348-52. PubMed ID: 19157643
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of healthcare-associated pneumonia (HCAP).
Zilberberg MD; Shorr AF
Semin Respir Crit Care Med; 2009 Feb; 30(1):10-5. PubMed ID: 19199182
[TBL] [Abstract][Full Text] [Related]
11. Should antibiotic combinations be used to treat ventilator-associated pneumonia?
Eggimann P; Revelly JP
Semin Respir Crit Care Med; 2006 Feb; 27(1):68-81. PubMed ID: 16508883
[TBL] [Abstract][Full Text] [Related]
12. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
13. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H
Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of resistance of bacteria causing ventilator-associated pneumonia.
Szabo D; Silveira F; Fujitani S; Paterson DL
Clin Chest Med; 2005 Mar; 26(1):75-9. PubMed ID: 15802168
[TBL] [Abstract][Full Text] [Related]
16. [Bacterial etiology of nosocomial pneumonia and antimicrobial resistance in patients with and without antimicrobial treatment].
Weyland B; Perazzi B; García S; Rodríguez C; Vay C; Famiglietti A
Rev Argent Microbiol; 2011; 43(1):18-23. PubMed ID: 21491061
[TBL] [Abstract][Full Text] [Related]
17. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
18. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
[TBL] [Abstract][Full Text] [Related]
19. The microbiology of ventilator-associated pneumonia.
Park DR
Respir Care; 2005 Jun; 50(6):742-63; discussion 763-5. PubMed ID: 15913466
[TBL] [Abstract][Full Text] [Related]
20. Update on the treatment of Pseudomonas aeruginosa pneumonia.
El Solh AA; Alhajhusain A
J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
